Document is current
Any future updates will be listed below
-
Authors
de Filippis, Renato https://orcid.org/0000-0001-6928-1224
Aloi, Matteo https://orcid.org/0000-0001-5585-6488
Pilieci, Anna Maria
Carbone, Elvira Anna https://orcid.org/0000-0001-5521-6552
Rania, Marianna https://orcid.org/0000-0001-7742-7086
D’Onofrio, Ettore https://orcid.org/0009-0008-8665-3649
Procopio, Claudia
Segura-Garcia, Cristina https://orcid.org/0000-0002-5756-3045
De Fazio, Pasquale https://orcid.org/0000-0001-5375-3565
- License Information
-
More Information
Article History
Received: 6 June 2026
Accepted: 19 August 2026
First Online: 31 August 2026
Declarations
Ethics approval and consent to participate: Before data collection, the study protocol underwent review and approval by the local Ethical Committee of University Hospital Mater Domini of Catanzaro (Italy), “Regione Calabria, sezione Area Centro” (n. 191/2020), and patients’ written informed consents have been collected. All procedures complied with the principles of the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: In the last three years, Dr. de Filippis has received speaker fee from Angelini, Johnson & Johnson, Lundbeck, Neuraxpharm, and Rovi, and travel support from Angelini, Idorsia, Johnson & Johnson, Lundbeck, Otsuka and Rovi. All other authors declare no competing interests.
